Do telomerase antagonists represent a novel anti-cancer strategy?
Br J Cancer
.
1996 Jan;73(1):1-4.
doi: 10.1038/bjc.1996.1.
Author
E K Parkinson
PMID:
8554968
PMCID:
PMC2074295
DOI:
10.1038/bjc.1996.1
No abstract available
Publication types
Editorial
Review
MeSH terms
Animals
Antineoplastic Agents / pharmacology*
Enzyme Inhibitors / pharmacology*
Humans
Telomerase / antagonists & inhibitors*
Substances
Antineoplastic Agents
Enzyme Inhibitors
Telomerase